David J Yvars Group bought a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,770 shares of the company’s stock, valued at approximately $499,000.
A number of other hedge funds also recently made changes to their positions in ALAB. Hollencrest Capital Management bought a new stake in Astera Labs in the 3rd quarter worth approximately $26,000. ORG Wealth Partners LLC purchased a new position in shares of Astera Labs in the fourth quarter valued at $42,000. US Bancorp DE bought a new stake in Astera Labs in the third quarter worth $46,000. First Horizon Advisors Inc. purchased a new stake in Astera Labs during the third quarter valued at $49,000. Finally, Allworth Financial LP raised its stake in Astera Labs by 445.5% during the third quarter. Allworth Financial LP now owns 1,091 shares of the company’s stock valued at $57,000 after purchasing an additional 891 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
ALAB has been the topic of a number of research reports. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating and boosted their target price for the stock from $100.00 to $120.00 in a report on Thursday, January 2nd. Craig Hallum raised their price objective on shares of Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Stifel Nicolaus lifted their target price on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $105.75.
Insiders Place Their Bets
In other news, Director Stefan A. Dyckerhoff sold 50,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $89.70, for a total transaction of $4,485,000.00. Following the sale, the director now directly owns 129,617 shares of the company’s stock, valued at $11,626,644.90. This represents a 27.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Sanjay Gajendra sold 740,000 shares of Astera Labs stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $96.59, for a total value of $71,476,600.00. Following the completion of the transaction, the insider now owns 775,000 shares of the company’s stock, valued at approximately $74,857,250. This represents a 48.84 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,690,452 shares of company stock worth $167,581,256.
Astera Labs Price Performance
Shares of Astera Labs stock opened at $127.19 on Tuesday. The firm has a fifty day moving average price of $116.88 and a 200 day moving average price of $74.77. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The business had revenue of $113.10 million during the quarter, compared to analyst estimates of $97.50 million. The company’s revenue was up 47.1% compared to the same quarter last year. As a group, equities analysts expect that Astera Labs, Inc. will post -0.45 EPS for the current year.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- Canada Bond Market Holiday: How to Invest and Trade
- Is a Ford Stock Turnaround on the Horizon?
- Consumer Staples Stocks, Explained
- What PMI Data Says About the NFP Report: 3 Hidden Opportunities
- Why Are Stock Sectors Important to Successful Investing?
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.